Halloran P, Roetering H, Pisani T, van den Berg B, Cobbaert C
Diagnostics Research and Development, Genzyme Diagnostics, Cambridge, Mass 02139, USA.
Arch Pathol Lab Med. 1999 Apr;123(4):317-26. doi: 10.5858/1999-123-0317-RSAAPO.
The use of high-density lipoprotein cholesterol (HDL-C) levels as a risk factor for coronary heart disease necessitates an accurate and precise method for measuring HDL-C. The Centers for Disease Control and Prevention HDL-C reference method (RM) and designated comparison method (DCM) are time-consuming, expensive, and impractical for routine clinical use. We evaluated the Liquid N-geneous (LN-gen) HDL-C assay (Genzyme Diagnostics, Cambridge, Mass) to determine if this homogeneous reagent meets the National Cholesterol Education Program requirements for HDL-C evaluation.
Accuracy of the LN-gen HDL-C assay was compared in combination with phosphotungstic acid (PTA) precipitation with DCM HDL-C for normotriglyceridemic serum specimens (triglycerides < 2.0 g/L) and with RM HDL-C for specimens with triglycerides levels > or = 2.0 g/L.
Genzyme Diagnostics (with RM and DCM assayed by Pacific BioMetrics Inc, Seattle, Wash) and the Lipid Reference Laboratory of the University Hospital Rotterdam, The Netherlands.
Linear regression to DCM (n = 90) was (LN-gen = 1.015 DCM + 0.01 g/L, r = 0.993, SE = 0.015 g/L) and (PTA = 1.004 DCM - 0.017 g/L, r = 0.980, SE = 0.025 g/L), with a mean percent bias to DCM of 3.3% and -2.8% for LN-gen and PTA, respectively. The comparison with RM (n = 69) showed an increased mean bias for PTA (-5.8%) as compared with LN-gen (1.5%). The correlation and regression equations were (LN-gen = 1.020 RM - 0.002 g/L, r = 0.985, SE = 0.017 g/L) and (PTA = 1.042 RM - 0.032 g/L, r = 0.984, SE = 0.018 g/L). The precision of LN-gen was confirmed at < 2.1% coefficient of variation, and the total error was calculated to be < or = 7.7% for both normotriglyceride and elevated triglyceride specimens at HDL-C decision points of 0.35 g/L and 0.60 g/L.
The LN-gen HDL-C assay offers a cost-effective convenient method for meeting the 1998 precision, bias, and total error recommendations of the National Cholesterol Education Program.
将高密度脂蛋白胆固醇(HDL-C)水平用作冠心病的危险因素,需要一种准确且精确的HDL-C测量方法。疾病控制与预防中心的HDL-C参考方法(RM)和指定比较方法(DCM)耗时、昂贵,且不适合常规临床应用。我们评估了液态均相(LN-gen)HDL-C检测法(Genzyme Diagnostics公司,马萨诸塞州剑桥),以确定这种均相试剂是否符合国家胆固醇教育计划对HDL-C评估的要求。
将LN-gen HDL-C检测法与磷钨酸(PTA)沉淀法相结合,分别针对正常甘油三酯血症血清标本(甘油三酯<2.0 g/L)与DCM HDL-C进行比较,针对甘油三酯水平≥2.0 g/L的标本与RM HDL-C进行比较,评估LN-gen HDL-C检测法的准确性。
Genzyme Diagnostics公司(由华盛顿州西雅图的Pacific BioMetrics公司进行RM和DCM检测)以及荷兰鹿特丹大学医院脂质参考实验室。
与DCM相比(n = 90),线性回归结果为(LN-gen = 1.015 DCM + 0.01 g/L,r = 0.993,SE = 0.015 g/L)以及(PTA = 1.004 DCM - 0.017 g/L,r = 0.980,SE = 0.025 g/L),LN-gen和PTA相对于DCM的平均偏差百分比分别为3.3%和 -2.8%。与RM相比(n = 69),PTA的平均偏差(-5.8%)高于LN-gen(1.5%)。相关及回归方程分别为(LN-gen = 1.020 RM - 0.002 g/L,r = 0.985,SE = 0.017 g/L)以及(PTA = 1.042 RM - 0.032 g/L,r = 0.984,SE = 0.018 g/L)。LN-gen的精密度在变异系数<2.1%时得到确认,对于HDL-C判定点为0.35 g/L和0.60 g/L的正常甘油三酯和甘油三酯升高的标本,计算得出的总误差均≤7.7%。
LN-gen HDL-C检测法提供了一种经济高效且便捷的方法,可满足国家胆固醇教育计划1998年对精密度、偏差和总误差的建议。